In a healthy condition, IL-22 cannot initiate tumor formation by itself and maintains barrier integrity against cancer development; but under inflammatory conditions, IL-22 directly promotes tumor growth or induces “stemness-like” cancer cells via STAT3-dependent signaling. The gene discussed is STAT3; the disease is neoplasm.